Logan Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-328
Closed -$16K 534
2022
Q3
$16K Hold
328
﹤0.01% 401
2022
Q2
$19K Hold
328
﹤0.01% 401
2022
Q1
$17K Hold
328
﹤0.01% 419
2021
Q4
$20K Hold
328
﹤0.01% 422
2021
Q3
$18K Sell
328
-172
-34% -$9.45K ﹤0.01% 428
2021
Q2
$26K Hold
500
﹤0.01% 405
2021
Q1
$22K Buy
+500
New +$21K ﹤0.01% 397

Other funds holding PBH

Logan Capital Management's PBH Position: Q4 2022 in Review

Logan Capital Management sold out of Prestige Consumer Healthcare (PBH) in Q4 2022, closing a stake of 328 shares — an estimated $16K sold.

Logan Capital Management first reported a position in PBH in Q1 2021 and held it in 7 quarters. The position peaked at $26K in Q2 2021. 289 funds tracked by Wall St. Rank hold PBH as of Q4 2022.

  • Logan Capital Management reported no remaining Prestige Consumer Healthcare position as of Q4 2022 after selling out during the quarter.
  • Logan Capital Management sold 328 Prestige Consumer Healthcare shares in Q4 2022, an estimated $16K.
  • Logan Capital Management first reported a position in Prestige Consumer Healthcare in Q1 2021 and held it in 7 quarters.
  • Logan Capital Management's Prestige Consumer Healthcare position peaked at $26K in Q2 2021.
  • 289 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2022.

Based on Logan Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.